دورية أكاديمية

The Madison Avenue effect: How drug presentation style influences adherence and outcome in patients with asthma.

التفاصيل البيبلوغرافية
العنوان: The Madison Avenue effect: How drug presentation style influences adherence and outcome in patients with asthma.
المؤلفون: Clerisme-Beaty, Emmanuelle M., Bartlett, Susan J., Teague, W. Gerald, Lima, John, Irvin, Charles G., Cohen, Rubin, Castro, Mario, Wise, Robert A., Rand, Cynthia S.
المصدر: Journal of Allergy & Clinical Immunology; Feb2011, Vol. 127 Issue 2, p406-411, 6p
مصطلحات موضوعية: HEALTH education, ASTHMATICS, PATIENT monitoring, PATIENT compliance, HEALTH expectancy, BRONCHODILATOR agents, QUALITY of life, HEALTH outcome assessment, MADISON Avenue (New York, N.Y.)
مصطلحات جغرافية: NEW York (N.Y.), NEW York (State)
مستخلص: Background: Little is known about how drug presentation influences medication adherence. Objective: To examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence. Methods: Data are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥80% use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV1, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up. Results: Average electronic medication adherence was 69.9%. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P < .001) and better medication adherence (odds ratio, 4.0; 95% CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence. Conclusion: The use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Allergy & Clinical Immunology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:00916749
DOI:10.1016/j.jaci.2010.11.038